NantKwest to Present at 2018 Cantor Global Healthcare Conference
October 02 2018 - 12:02PM
Business Wire
NantKwest (Nasdaq:NK), a leading, clinical-stage natural killer
cell based therapeutics company, today announced that the company
will be presenting at the upcoming Cantor Global Healthcare
Conference on Tuesday, October 2nd in New York City During the
conference, company management will be presenting a corporate
overview, as well as conducting one-on-one meetings to provide a
corporate update, as well as review R&D and clinical
activities.
Conference Details:
Event: Cantor Global Healthcare Conference Date/Time:
Tuesday, October 2, 2018 at 4:00pm Location: New York, NY
About NantKwest Inc.
NantKwest is an innovative clinical-stage immunotherapy company
focused on harnessing the power of the innate immune system by
using the natural killer cell to treat cancer, infectious diseases
and inflammatory diseases.
NantKwest is uniquely positioned to implement precision cancer
medicine, with the potential to change the current paradigm of
cancer care. Natural Killer cells are ancient cells in the human
body designed to recognize and detect cells under stress or
infected. The NantKwest “off-the-shelf” activated Natural Killer
(NK) platform has the capacity to destroy cancer and virally
infected cells from the body. The safety of our NK cells as well as
their activity against a broad range of cancers have been tested in
multiple phase 1 clinical trials in the United States, Canada and
Europe. In addition to our NK cells capability to be administered
in the outpatient setting as an “off-the-shelf” living drug, it
serves as a universal cell-based therapy without need for
individualized patient matching. Moreover, our NK cell based
platform has been bioengineered to incorporate chimeric antigen
receptors (CARs) and antibody receptors to further optimize
targeting and potency in the therapeutic disease.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20181002005835/en/
NantKwest Inc.Media Contact:Jen
Hodsonjhodson@nantworks.comorInvestor Contact:David Pyrce,
951-551-0949david.pyrce@nantkwest.com
NantKwest (NASDAQ:NK)
Historical Stock Chart
From Mar 2024 to Apr 2024
NantKwest (NASDAQ:NK)
Historical Stock Chart
From Apr 2023 to Apr 2024